Diagnosis and treatment of eosinophilic esophagitis

NP Gonsalves, SS Aceves - Journal of Allergy and Clinical Immunology, 2020 - Elsevier
Eosinophilic esophagitis (EoE) is an eosinophil-rich, TH 2 antigen–mediated disease of
increasing pediatric and adult worldwide prevalence. Diagnosis requires greater than or …

Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis

P Visaggi, B Barberio, G Del Corso, N de Bortoli… - Gut, 2023 - gut.bmj.com
Background There is currently no recommendation regarding preferred drugs for active
eosinophilic oesophagitis (EoE) because their relative efficacy is unclear. We conducted an …

Eosinophilic gastrointestinal diseases-Pathogenesis, diagnosis, and treatment

Y Kinoshita, S Oouchi, T Fujisawa - Allergology International, 2019 - jstage.jst.go.jp
abstract Eosinophilic gastrointestinal diseases (EGIDs) are divided into eosinophilic
esophagitis (EoE) and eosinophilic gastroenteritis (EGE), depending on the involved …

A network meta-analysis of randomized controlled trials on the treatment of eosinophilic esophagitis in adults and children

T Rokkas, Y Niv, P Malfertheiner - Journal of clinical …, 2021 - journals.lww.com
Background: Network meta-analysis is used as a data synthesizer, incorporating direct and
indirect evidence about treatments in a series of randomized control trials. Objective: To …

Treatment of eosinophilic esophagitis: diet or medication?

M Chehade, SS Aceves - The Journal of Allergy and Clinical Immunology …, 2021 - Elsevier
Eosinophilic esophagitis (EoE) is an antigen-triggered chronic disease of increasing
prevalence in children and adults. Untreated or therapy-resistant EoE leads to complications …

Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 …

I Hirano, ES Dellon, SK Gupta… - Alimentary …, 2023 - Wiley Online Library
Background Questions remain regarding the safety of swallowed topical corticosteroids in
eosinophilic oesophagitis (EoE). Aim To assess the safety of an investigational formulation …

A meta-analysis on randomized controlled trials of treating eosinophilic esophagitis with budesonide

X Liu, X **ao, D Liu, C Tan - Annals of Medicine, 2022 - Taylor & Francis
Abstract Objective Eosinophilic esophagitis (EoE) is a chronic, local immune-mediated
inflammatory oesophageal disease. Although Budesonide is recommended as one of the …

Systemic administration of budesonide in pegylated liposomes for improved efficacy in chronic rhinosinusitis

B Yathavan, A Ellis, J Jedrzkiewicz… - Journal of Controlled …, 2023 - Elsevier
Chronic rhinosinusitis (CRS) is a chronic inflammatory condition affecting the nasal and
paranasal sinuses of approximately 11.5% of the United States adult population. Oral …

[HTML][HTML] A practical update on pediatric eosinophilic esophagitis

M Votto, M De Filippo, S Caimmi, C Indolfi, A Raffaele… - Children, 2023 - mdpi.com
Eosinophilic esophagitis (EoE) is an emerging atopic disease of unknown etiology limited to
the esophagus. The pathogenesis is still understood and is likely characterized by type 2 …

Formulations of Topical Steroids in Eosinophilic Esophagitis—Current Treatment and Emerging Possibilities

A Główczewski, A Krogulska - Journal of Clinical Medicine, 2022 - mdpi.com
Eosinophilic esophagitis (EoE) is a chronic immune-mediated disorder characterised by
eosinophilic inflammation and esophageal dysfunction symptoms. The recommended first …